RE: Hoping for a positive RnS, suspension lifted!11 Mar 2022 07:32
While it is a good start, they have left CEO Alexey Ivanov as a director. The FCA de-listing was specifically concerned with people that have ability to direct the company.
"Whilst this is clearly disappointing, our plans do not include any contribution from COVID-19 antigen tests..." This is somewhat reassuring. Sounds like they have not been expecting any sales from VISITECT, so hopefully this shouldn't affect the bottom line
"Currently, with insufficient demand for the professional-use test, the Company does not plan to commission further studies at this time." Sounds like they were ready to write the VISITECT product off as a dead duck anyway.
That's my take as well - it's a good update, BOO are doing well, in line with their guidance. I don't expect much more in share price today, perhaps a modest increase.
Still risky - the dividend won't be paid until 30 March. A lot could happen between now and then. If the company is de-listed, then will that mean the dividends will not be paid?
I see a placeholder in my shares account the extra "EXCESS APP (169P)" shares a opted for in the open offer. I take it that yesterday's RNS ("Open Offer will not take place") means that those shares will disappear and the money returned? Or did yesterday's RNS refer to a different Open Offer?
40% of EVR revenue and 85% of their steel production is in Russia. What is the chance that sanctions will prevent EVR selling? I assume very high, explaining the recent 85% drop in share price.